Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Contemporary Clinical Trials
|
September 26, 2013
Sample size and threshold estimation for clinical trials with predictive biomarkers
Howard M Mackey, Thomas Bengtsson
Contemporary Clinical Trials
|
February 24, 2018
The use of methacholine provocation when assessing therapeutic equivalence between two inhalers in asthmatic patients
Thomas Bengtsson, Jonas Román, Tore Persson
BMC Pulmonary Medicine
|
March 28, 2014
Transient paradoxical bronchospasm associated with inhalation of the LAMA AZD9164: analysis of two Phase I, randomised, double-blind, placebo-controlled studies
Carin Jorup, Thomas Bengtsson, Kerstin Strandgården, et al.
Drug Design, Development and Therapy
|
November 3, 2025
Relative Bioavailability of Inhaled Fluticasone Propionate and Salmeterol - is Population Pharmacokinetic Modelling a Relevant Alternative to a Non-Compartmental Approach?
Johan Rosenborg, Per Bäckman, Thomas Bengtsson, et al.
Therapeutic Advances in Respiratory Disease
|
August 3, 2013
Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma
Leif Bjermer, Johan Rosenborg, Thomas Bengtsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 21, 2025
Reply to: Automatic for the People: What Has Machine Learning Analysis of Positron Emission Tomography Left for the Physician?
Skander Jemaa, Thomas Bengtsson, Richard A D Carano
Respiratory Medicine
|
October 27, 2012
Local and systemic effects of inhaled AZD9164 compared with tiotropium in patients with COPD
Leif Bjermer, Thomas Bengtsson, Carin Jorup, et al.
British Journal of Clinical Pharmacology
|
January 25, 2007
Site of deposition and absorption of an inhaled hydrophilic solute
Eva Bondesson, Thomas Bengtsson, Lars-Erik Nilsson, et al.
Journal of Breath Research
|
March 9, 2011
Exhaled breath condensate-site and mechanisms of formation
Eva Bondesson, Lennart T Jansson, Thomas Bengtsson, et al.
The European Respiratory Journal
|
September 1, 2018
The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD
Dave Singh, Katharine Abbott-Banner, Thomas Bengtsson, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Contemporary Clinical Trials
|
September 26, 2013
Sample size and threshold estimation for clinical trials with predictive biomarkers
Howard M Mackey, Thomas Bengtsson
Contemporary Clinical Trials
|
February 24, 2018
The use of methacholine provocation when assessing therapeutic equivalence between two inhalers in asthmatic patients
Thomas Bengtsson, Jonas Román, Tore Persson
BMC Pulmonary Medicine
|
March 28, 2014
Transient paradoxical bronchospasm associated with inhalation of the LAMA AZD9164: analysis of two Phase I, randomised, double-blind, placebo-controlled studies
Carin Jorup, Thomas Bengtsson, Kerstin Strandgården, et al.
Drug Design, Development and Therapy
|
November 3, 2025
Relative Bioavailability of Inhaled Fluticasone Propionate and Salmeterol - is Population Pharmacokinetic Modelling a Relevant Alternative to a Non-Compartmental Approach?
Johan Rosenborg, Per Bäckman, Thomas Bengtsson, et al.
Therapeutic Advances in Respiratory Disease
|
August 3, 2013
Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma
Leif Bjermer, Johan Rosenborg, Thomas Bengtsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 21, 2025
Reply to: Automatic for the People: What Has Machine Learning Analysis of Positron Emission Tomography Left for the Physician?
Skander Jemaa, Thomas Bengtsson, Richard A D Carano
Respiratory Medicine
|
October 27, 2012
Local and systemic effects of inhaled AZD9164 compared with tiotropium in patients with COPD
Leif Bjermer, Thomas Bengtsson, Carin Jorup, et al.
British Journal of Clinical Pharmacology
|
January 25, 2007
Site of deposition and absorption of an inhaled hydrophilic solute
Eva Bondesson, Thomas Bengtsson, Lars-Erik Nilsson, et al.
Journal of Breath Research
|
March 9, 2011
Exhaled breath condensate-site and mechanisms of formation
Eva Bondesson, Lennart T Jansson, Thomas Bengtsson, et al.
The European Respiratory Journal
|
September 1, 2018
The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD
Dave Singh, Katharine Abbott-Banner, Thomas Bengtsson, et al.
Page
of 7